The Treatment of Psychotic Major Depression: Is There a Role for Adjunctive Psychotherapy?Gaudiano B.A.a · Miller I.W.a · Herbert J.D.b
aDepartment of Psychiatry and Human Behavior, Brown Medical School and Butler Hospital, Providence, R.I., and bDepartment of Psychology, Drexel University, Philadelphia, Pa., USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Background: Psychotic depression is a relatively prevalent mood disorder associated with greater symptom severity, a poorer course of illness and higher levels of functional impairment compared with nonpsychotic depression. Separate lines of investigation suggest that various forms of cognitive-behavioral therapy are efficacious for treating severe forms of nonpsychotic depression as well as primary psychotic disorders. However, there currently are no empirically supported psychotherapies specifically designed for treating psychotic depression. Method: We review the efficacy of current somatic treatments for the disorder and discuss the limited data to date on potentially useful psychotherapeutic approaches. In particular, we describe the clinical improvement observed in a subgroup of hospitalized patients with psychotic depression treated with Acceptance and Commitment Therapy as part of a larger clinical trial. Results: Pilot results demonstrated that Acceptance and Commitment Therapy was associated with clinically significant reductions in acute symptom severity and impairment compared with treatment as usual. Conclusion: The findings suggest that patients with psychotic depression can benefit from psychotherapy. Clinical and research recommendations in this area are presented.
© 2007 S. Karger AG, Basel
- Ohayon MM, Schatzberg AF: Prevalence of depressive episodes with psychotic features in the general population. Am J Psychiatry 2002;159:1855–1861.
- Johnson J, Horwath E, Weissman MM: The validity of major depression with psychotic features based on a community sample. Arch Gen Psychiatry 1991;48:1075–1081.
- Coryell W, Pfohl B, Zimmerman M: The clinical and neuroendocrine features of psychotic depression. J Nerv Ment Dis 1984;172:521–528.
- Rothschild AJ, Benes F, Hebben N, Woods B, Luciana M, Bakanas E, Samson JA, Schatzberg AF: Relationships between brain CT scan findings and cortisol in psychotic and nonpsychotic depressed patients. Biol Psychiatry 1989;26:565–575.
- Vega JAW, Mortimer AM, Tyson PJ: Somatic treatment of psychotic depression: review and recommendations for practice. J Clin Psychopharmacol 2000;20:504–519.
- Tyrka AR, Price LH, Mello MF, Mello AF, Carpenter LL: Psychotic major depression: a benefit-risk assessment of treatment options. Drug Saf 2006;29:491–508.
- Serretti A, Lattuada E, Cusin C, Gasperini M, Smeraldi E: Clinical and demographic features of psychotic and nonpsychotic depression. Compr Psychiatry 1999;40:358–362.
- Lattuada E, Serretti A, Cusin C, Gasperini M, Smeraldi E: Symptomatologic analysis of psychotic and non-psychotic depression. J Affect Disord 1999;54:183–187.
- Thakur M, Hays J, Kishnan KRR: Clinical, demographic and social characteristics of psychotic depression. Psychiatry Res 1999;86:99–106.
- Coryell W, Keller M, Lavori P, Endicott J: Affective syndromes, psychotic features, and prognosis. I. Depression. Arch Gen Psychiatry 1990;47:651–657.
- Tohen M, Hennen J, Zarate CM Jr, Baldessarini RJ, Strakowski SM, Stoll AL, Faedda GL, Suppes T, Gebre-Medhin P, Cohen BM: Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry 2000;157:220–228.
- Coryell W, Leon A, Winokur G, Endicott J, Keller M, Akiskal H, Solomon D: Importance of psychotic features to long-term course in major depressive disorder. Am J Psychiatry 1996;153:483–489.
- Gaudiano BA, Beevers CG, Miller IW: Differential response to combined treatment in patients with psychotic versus nonpsychotic major depression. J Nerv Ment Dis 2005;193:625–628.
- Schatzberg AF, Rothschild AJ: Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV? Am J Psychiatry 1992;149:733–745.
- Rothschild AJ: Management of psychotic, treatment-resistant depression. Psychiatr Clin North Am 1996;19:237–252.
Wijkstra J, Lijmer J, Balk F, Geddes J, Nolen WA: Pharmacological treatment for psychotic depression. Cochrane Database Syst Rev 2005;4:CD004044.
- Parker G, Roy K, Hadzi-Pavlovic D, Pedic F: Psychotic (delusional) depression: a meta-analysis of physical treatments. J Affect Disord 1992;24:17–24.
- Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353:1209–1223.
Bishop S, Miller IW, Norman W, Buda M, Foulke M: Cognitive therapy of psychotic depression: a case report. Psychotherapy 1986;23:167–173.
- DeRubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, O’Reardon JP, Lovett ML, Gladis MM, Brown LL, Gallop R: Cognitive therapy vs. medications in the treatment of moderate to severe depression. Arch Gen Psychiatry 2005;62:409–416.
- Friedman M, Detweiler-Bedell J, Leventhal H, Horne R, Keitner G, Miller I: Combined psychotherapy and pharmacotherapy for the treatment of major depressive disorder. Clin Psychol Sci Pract 2004;11:47–68.
Gaudiano BA: Cognitive behavior therapies for psychotic disorders: current empirical status and future directions. Clin Psychol Sci Pract 2005;12:33–50.
- Tarrier N: Cognitive behaviour therapy for schizophrenia – a review of development, evidence and implementation. Psychother Psychosom 2005;74:136–144.
- Trower P, Birchwood M, Meaden A, Byrne S, Nelson A, Ross K: Cognitive therapy for command hallucinations: randomised controlled trial. Br J Psychiatry 2004;184:312–320.
Hayes SC, Strosahl KD, Wilson K: Acceptance and Commitment Therapy. An Experiential Approach to Behavior Change. New York, Guilford, 1999.
Linehan MM: Cognitive-Behavioral Treatment of Borderline Personality Disorder. New York, Guilford, 1993.
- Hayes SC, Luoma JB, Bond FW, Masuda A, Lillis J: Acceptance and commitment therapy: model, processes and outcomes. Behav Res Ther 2006;44:1–25.
Beck AT, Rush AJ, Shaw BF, Emery G: Cognitive Therapy for Depression. New York, Guilford, 1979.
- Kashdan TB, Barrios V, Forsyth JP, Steger MF: Experiential avoidance as a generalized psychological vulnerability: comparisons with coping and emotion regulation strategies. Behav Res Ther 2006;44:1301–1320.
- Wenzlaff RM, Bates DE: Unmasking a cognitive vulnerability to depression: how lapses in mental control reveal depressive thinking. J Pers Soc Psychol 1998;75:1559–1571.
- Tait L, Birchwood M, Trower P: Adapting to the challenge of psychosis: personal resilience and the use of sealing-over (avoidant) coping strategies. Br J Psychiatry 2004;185:410–415.
- Bach P, Hayes SC: The use of acceptance and commitment therapy to prevent the rehospitalization of psychotic patients: a randomized controlled trial. J Consult Clin Psychol 2002;70:1129–1139.
- Gaudiano BA, Herbert JD: Acute treatment of inpatients with psychotic symptoms using Acceptance and Commitment Therapy: pilot results. Behav Res Ther 2006;44:415–437.
Bach P, Gaudiano BA, Pankey J, Herbert JD, Hayes SC: Acceptance, mindfulness, values and psychosis: applying Acceptance and Commitment Therapy (ACT) to the chronically mentally ill; in Baer RA (ed): Mindfulness-Based Treatment Approaches. Clinician’s Guide to Evidence Base and Applications. New York, Academic Press, 2006, pp 93–116.
Overall G, Gorham D: The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799–812.
Kingdon DG, Turkington D: Cognitive Therapy of Schizophrenia. New York, Guilford, 2005.
- Fava GA, Ruini C, Rafanelli C: Sequential treatment of mood and anxiety disorders. J Clin Psychiatry 2005;66:1392–1400.
- Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau MA: Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol 2000;68:615–623.
- Turkington D, Kingdon D, Rathod S, Hammond K, Pelton J, Mehta R: Outcomes of an effectiveness trial of cognitive-behavioural intervention by mental health nurses in schizophrenia. Br J Psychiatry 2006;189:36–40.
- Sethi S, Bhargava SC: Relationship of meditation and psychosis: case studies. Aust NZ J Psychiatry 2003;37:382.
- Keller J, Gomez RG, Kenna HA, Poesner J, DeBattista C, Flores B, Schatzberg AF: Detecting psychotic major depression using psychiatric rating scales. J Psychiatr Res 2006;40:22–29.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.